Changeflow GovPing Healthcare & Life Sciences USPTO Grants Patent for Therapeutic Gas Deliver...
Routine Notice Added Final

USPTO Grants Patent for Therapeutic Gas Delivery Cart

Favicon for changeflow.com USPTO Patent Grants - Prosthetics (A61F)
Published
Detected
Email

Summary

The USPTO has granted a design patent (USD1120338S1) for a therapeutic gas delivery cart to Mallinckrodt Pharmaceuticals Ireland Limited. The patent, which covers the design of the cart, was granted on March 24, 2026, with a filing date of June 17, 2025.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has issued a design patent, USD1120338S1, for a therapeutic gas delivery cart. The patent was granted to Mallinckrodt Pharmaceuticals Ireland Limited, with inventors Brian McCormack, Michael McAtamney, and Jaron Matthew Acker. This patent specifically covers the ornamental design of the cart, not its functional aspects or efficacy, and is classified under CPC codes related to medical devices and gas delivery systems.

This patent grant signifies the protection of the unique visual appearance of the therapeutic gas delivery cart. While it does not impose new regulatory obligations on other manufacturers or healthcare providers, it establishes intellectual property rights for Mallinckrodt Pharmaceuticals. Companies developing or manufacturing similar gas delivery carts should be aware of this patent to avoid potential infringement claims and ensure their designs do not mimic the protected ornamental features.

What to do next

  1. Review patent details for potential design overlap if manufacturing similar devices.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Therapeutic gas delivery cart

Design USD1120338S1 Kind: S1 Mar 24, 2026

Assignee

Mallinckrodt Pharmaceuticals Ireland Limited

Inventors

Brian McCormack, Michael McAtamney, Jaron Matthew Acker

CPC Classifications

A61F 9/007 A61F 9/00745 A61F 9/008 A61B 50/13 A61B 50/10 A61B 5/742

Filing Date

2025-06-17

Application No.

30008765

Claims

1

View original document →

Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
USD1120338S1

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Design
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!